LINC01885

Across TCGA pan-cancer cohorts, LINC01885 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC01885’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC01885 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01885 is over-expressed in tumor, although a few such as THCA and HNSC show the opposite, repressed pattern.

THCA, KIRC, and HNSC are the cancer types where LINC01885 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01885 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	−2.901	<.001	11	view →
KIRC	All	III,IV	+0.389	<.001	10	view →
HNSC	All	All	−0.085	.014	5	view →
LUSC	All	All	+0.109	.004	2	view →
KICH	All	II,III,IV	−0.054	.041	1	view →
LIHC	All	All	+0.043	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC01885–THCA

Open the THCA breakdown →